Search
forCommunity 10 of 170
- The fear mongering of 5AR inhibitors
- Guys if you can’t take 5AR inhibitors still get on treatment ASAP
- Why is the general consensus that if you can’t tolerate 5AR Inhibitors you’re “cooked”?
- Can gains from stemoxydine be permanently kept with 5AR inhibitors?
- Whoever had success with PYRILUTAMIDE, please give us hope outside of 5AR inhibitors.
- A better treatment would be a localized 5ar inhibitor that breaks down when it enters blood or leaves hair follicle
- Similar 5ar inhibitors to fin?
- Is there any role for topical DHT antagonists, or does a 5-AR inhibitor remove the need for them as therapy
- BREAKTHROUGH: I’m a radiochemist and discovered a radioactive isotope scalp serum that OUTPERFORMS Minoxidil and 5-AR inhibitors! (Lab Data Inside)
- Why does this industry still revolve around 5-AR inhibitors?
Research 10 of 326
- HPLC characterization, molecular docking, QSAR and molecular dynamics simulation of Alstonia boonei phytochemical analogs as potent 5-alpha reductase inhibitors
- Computational drug discovery of potential 5α-reductase phytochemical inhibitors and hair growth promotion using in silico techniques
- Table 2_Computational drug discovery of potential 5α-reductase phytochemical inhibitors and hair growth promotion using in silico techniques.xlsx
- Table 1_Computational drug discovery of potential 5α-reductase phytochemical inhibitors and hair growth promotion using in silico techniques.xlsx
- Intraethnic variation in steroid-5-alpha-reductase polymorphisms in prostate cancer patients: a potential factor implicated in 5-alpha-reductase inhibitor treatment
- Synthesis and Study of Some 17a-aza-D-homo Steroids as 5α-Reductase Inhibitors
- Association of 5α-Reductase Inhibitors With Dementia, Depression, and Suicide
- Analysis of Data From Breast Diseases Treated With 5-Alpha Reductase Inhibitors for Benign Prostatic Hyperplasia
- Effects of 5-alpha reductase inhibitors on erectile function, sexual desire and ejaculation
- Experimental Assessment of 3-<i>meta</i>-Pyridine-1,2,4-Oxadiazole Deoxycholic Acid Derivative as a Prototype of 5-α-Reductase Inhibitors <i>in silico</i> and <i>in vivo</i> Models